Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC

Although immune checkpoint inhibitors (ICIs) have shown remarkable benefit for treatment of advanced non-small lung cancer (NSCLC), only a minority of patients can achieve durable responses and the most patients produce an ultra-rapid progressive disease. Here, we collected the availably published d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhimin, Gu, Yanyan, Su, Xiaona, Bai, Jing, Guan, Wei, Ma, Jungang, Luo, Jia, He, Juan, Zhang, Bicheng, Geng, Mingying, Xia, Xuefeng, Guan, Yanfang, Shen, Cheng, Chen, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100434/
https://www.ncbi.nlm.nih.gov/pubmed/33968765
http://dx.doi.org/10.3389/fonc.2021.659321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100434/
https://www.ncbi.nlm.nih.gov/pubmed/33968765
http://dx.doi.org/10.3389/fonc.2021.659321

Ejemplares similares